Back
Monte Rosa Therapeutics Stock Predictions
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
11
GLUE
Monte Rosa Therapeutics
Last Price:
$7.05
Seasonality Move:
-4.72%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Monte Rosa Therapeutics Stock Forecast
-
Over the next 52 weeks, Monte Rosa Therapeutics has on average historically fallen by 21.8% based on the past 3 years of stock performance.
-
Monte Rosa Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Monte Rosa Therapeutics Stock Undervalued?The current Monte Rosa Therapeutics [GLUE] share price is $7.06. The Score for GLUE is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
GLUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Monte Rosa Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monte Rosa Therapeutics has on average historically fallen by 21.8% based on the past 3 years of stock performance.
Monte Rosa Therapeutics Stock Rating
Sell
11
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics overpriced?
-
Monte Rosa Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Monte Rosa Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monterosatx.com
52-Week Data
52-Week High:
12.40
52-Week Low:
3.21
Prediction Charts
Market Cap:
433.7M
Price in USD:
7.06
Volume:
828.2K
Beta:
1.40
Technical Analysis
SMA50:
8.10
SMA100:
6.79
SMA200:
5.94
52-Wk Change:
22.57%
Stock Predictions
-
Is Monte Rosa Therapeutics stock public?Yes, Monte Rosa Therapeutics is a publicly traded company.
-
What is the Monte Rosa Therapeutics stock quote today?The Monte Rosa Therapeutics stock price is 7.06 USD today.
-
How to buy Monte Rosa Therapeutics stock online?You can buy Monte Rosa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-9 | 9.57 | 10.20 | 10.21 | 9.40 |
| Dec-10 | 10.00 | 9.44 | 10.69 | 9.40 |
| Dec-11 | 9.34 | 8.51 | 9.84 | 8.50 |
| Dec-12 | 8.48 | 7.79 | 8.58 | 7.66 |
| Dec-13 | 7.87 | 7.56 | 8.24 | 7.50 |
| Dec-16 | 7.53 | 7.68 | 7.93 | 7.36 |
| Dec-17 | 7.62 | 7.67 | 7.95 | 7.52 |
| Dec-18 | 7.67 | 7.03 | 7.89 | 6.89 |
| Dec-19 | 6.81 | 6.51 | 6.83 | 6.15 |
| Dec-20 | 6.44 | 6.91 | 7.14 | 6.41 |
| Dec-23 | 6.90 | 7.14 | 7.22 | 6.89 |
| Dec-24 | 7.13 | 7.05 | 7.22 | 6.88 |
| Dec-26 | 6.93 | 7.22 | 7.35 | 6.86 |
| Dec-27 | 7.15 | 7.06 | 7.32 | 6.86 |
Monte Rosa Therapeutics Earnings
Monte Rosa Therapeutics Earnings Report: Per Share Monte Rosa Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monte Rosa Therapeutics Forecast Revenue Growth
Monte Rosa Therapeutics Stock Analysis: Historical quarterly revenues per share for Monte Rosa Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.28 per share, and a decrease next year of $0.48 per share.
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.